Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Health Catalyst Inc (NQ: HCAT )

8.520 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Health Catalyst Inc

< Previous 1 2 3 4 Next >
The Latest Analyst Ratings For Health Catalyst
Via Benzinga
Health Catalyst (NASDAQ:HCAT) Posts Q3 Sales In Line With Estimates
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 3.5% year on year to $76.35 million. The company expects next quarter’s... 
Via StockStory
Health Catalyst (HCAT) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare software provider Health Catalyst (NASDAQ:HCAT) will be reporting earnings tomorrow afternoon. Here’s what to look for. 
Via StockStory
What Analysts Are Saying About Health Catalyst Stock
Via Benzinga
Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts
Via Benzinga
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
Via Benzinga
The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts
Via Benzinga
A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
Via Benzinga
Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
3 Overlooked Telehealth Stocks Poised for a Comeback
Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement. 
Via InvestorPlace
Peeling Back The Layers: Exploring Health Catalyst Through Analyst Insights
Via Benzinga
HCAT Stock Earnings: Health Catalyst Beats EPS, Misses Revenue for Q1 2024
HCAT stock results show that Health Catalyst beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
What 7 Analyst Ratings Have To Say About Health Catalyst
Via Benzinga
SMART Global Reports Q2 Results, Joins Health Catalyst And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining by around 0.1% on Wednesday. 
Via Benzinga
Analyst Scoreboard: 5 Ratings For Health Catalyst
Via Benzinga
Demystifying Health Catalyst: Insights From 7 Analyst Reviews
Via Benzinga
Deep Dive Into Health Catalyst Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Expert Ratings for Health Catalyst
Via Benzinga
D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
Where Health Catalyst Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
7 Analysts Have This to Say About Health Catalyst
Via Benzinga
Alignment Healthcare's Valuation Shows Promise In A Competitive Market: Analyst
Alignment Healthcare Inc (NASDAQ: ALHC) announced that its California Medicare Advantage (MA) HMO – which represents roughly 89% of its MA membership – has maintained an overall 4 out of 5-star rating... 
Via Benzinga
Veeva Systems Stock Scores Rising Relative Strength Rating
The Relative Strength (RS) Rating for Veeva Systems stock climbed into a higher percentile Thursday, as it got a lift from 67 to 72. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
Via Benzinga
Health Catalyst's Q1 Earnings: Analysts Diverge on Outlook as Company Faces Demand Headwinds and Revenue Outperformance
Health Catalyst Inc (NASDAQ: HCAT) reported Q1 sales of $73.87 million, up 22% Y/Y, beating the consensus of $71.24 million< 
Via Benzinga
Nasdaq, S&P 500 Higher As Bond Yields Retreat
Investor sentiment is boosted today by a better-than-expected consumer price index (CPI) reading for April. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.